Perspective · 29 Dec 2025
Mini reviewPublished 29 Feb 2024
Advancements in the Treatment of Paragangliomas and Pheochromocytomas in the Era of Precision Medicine
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Paragangliomas and pheochromocytomas are rare neuroendocrine tumors originating from the chromaffin cells of the sympathetic and parasympathetic nervous systems, respectively. While traditionally managed through surgical resection and adjuvant therapies, the advent of precision medicine has revolutionized the approach to diagnosing, treating, and managing these tumors. This article explores the evolving landscape of treatment modalities for paragangliomas and pheochromocytomas in the era of precision medicine.
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Genetics and Genomes.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Genetics and Genomes
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Mockler Henk”
